Skip to main content
Filter By
Hearing
Mixed Signals: The Administration’s Stance on Marijuana, Part Two

Hearing
Alaska Bypass Mail Delivery: A Broken System

Press Release
Issa Statement on House Passage of Unfunded Mandates and Regulatory Transparency Bills

“Transparency and accountability will go a long way to addressing this Administration’s runaway expansion of the regulatory state,” Issa said. “These reforms bring job-killing federal mandates out of the dark by giving the public ample time to see and prepare for their real costs and economic impact. The reforms of Stop Government Abuse Week are a step in the right direction toward creating an open rulemaking process and undoing the economic damage of the federal government’s ...

Hearing
Examining the Endangered Species Act

Hearing
Afghanistan: Honoring the Heroes of Extortion 17

Hearing
The Administration’s Proposed Restrictions on Political Speech: Doubling Down on IRS Targeting

Hearing
Is the Obama Administration Conducting a Serious Investigation of IRS Targeting?

Press Release
Oversight Committee Recalls Lois Lerner, Former IRS Targeting Official, to Testify

“Ms. Lerner’s testimony remains critical to the Committee’s investigation,” wrote Chairman Issa. “Documents and testimony obtained by the Committee show that she played a significant role in scrutinizing applications for tax exempt status from conservative organizations. Documents also show that Ms. Lerner participated in “off plan” work to develop rules that would allow the IRS to stifle constitutionally protected political speech by non-profit groups. Ms. Lerner’s testimony ...

Report
Staff Report: Limitless Surveillance at the FDA: Protecting the Rights of Federal Whistleblowers

Key Findings: Insufficient authorization and guidelines. The monitoring was implemented with insufficient written authorization, no policy in place and no legal guidance given to the contractors conducting the monitoring. As a result, FDA captured communications that are protected by law, including communications with Congress, the media, and watchdog groups like Project on Government Oversight. Unlawful capturing ...

Press Release
Issa, Grassley Report on FDA Employee Monitoring Finds Agency Still Lacks Adequate Whistleblower Protections

WASHINGTON – Today, House Oversight and Government Reform Committee Chairman Darrell Issa, R-Calif., and Senate Judiciary Committee Ranking Member Chuck Grassley, R-Iowa, released a joint report on the U.S. Food and Drug Administration (FDA)’s highly-invasive surveillance program that monitored employees who contacted Congress and the media with concerns about FDA’s medical device approval process. In April 2010, the FDA initiated a surveillance ...